Agios Pharmaceuticals

Agios’ Tibsovo gains FDA approval as targeted AML treatment

The US Food and Drug Administration (FDA) has granted approval for Agios Pharmaceuticals' Tibsovo (ivosidenib) tablets to treat adults with…